TNFRSF10B and glioblastoma: Various mechanisms operating in glioblastoma cells have been involved in TRAIL resistance of these cells: FLIP overexpression due to its stabilization mediated by PTEN loss [24]; absent/low caspase-8 and/or TRAIL-R2 expression [25]; impaired cell death signaling originated from TRAIL-R activation [26].